EPI.MUNE
LIVE

Serial Number

79241465

Owner

Epimune GmbH

Attorney

Richard P. Georget, Esq.

Filing Date

May 31, 2018

Add to watchlist:

No watchlists yet
View on USPTO

EPI.MUNE Trademark

Serial Number: 79241465 • Registration: 6422140

EPI.MUNE is a trademark filed by Epimune GmbH on May 31, 2018. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

Epimune GmbH (3 trademarks)

Rudower Chaussee 29

Entity Type: 99

Trademark Details

Filing Date

May 31, 2018

Registration Date

July 20, 2021

Published for Opposition

May 4, 2021

Goods & Services

Reagents for medical diagnostic in the field of immunology; kits, containing reagents for medical diagnostic in the field of immunology

Medical and veterinary services in the field of Immunology

Apparatus and Instruments for medical purposes in the field of Immunology, namely, immunochemical testing apparatus for medical use, medical diagnostic apparatus for testing body liquids, body tissues, DNA and RNA samples of human or veterinary origin, for the detection and diagnosis of diseases, disorders, and conditions in the fields of oncology and immunology

Scientific and technological services in the field of Immunology, namely, medical research and medical laboratory services in the field of Immunology

Filing History

NEW REPRESENTATIVE AT IB RECEIVED
Apr 21, 2024 NREP
NEW REPRESENTATIVE AT IB RECEIVED
Feb 25, 2022 NREP
NEW REPRESENTATIVE AT IB RECEIVED
Feb 4, 2022 NREP
NEW REPRESENTATIVE AT IB RECEIVED
Jan 8, 2022 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Dec 5, 2021 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Nov 17, 2021 FICS
FINAL DISPOSITION PROCESSED
Nov 17, 2021 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Oct 20, 2021 FICR
REGISTERED-PRINCIPAL REGISTER
Jul 20, 2021 R.PR
NOTIFICATION PROCESSED BY IB
May 11, 2021 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 4, 2021 NPUB
PUBLISHED FOR OPPOSITION
May 4, 2021 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Apr 14, 2021 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Apr 14, 2021 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 14, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 30, 2021 CNSA
EXAMINER'S AMENDMENT ENTERED
Mar 30, 2021 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Mar 30, 2021 GNEN
EXAMINERS AMENDMENT E-MAILED
Mar 30, 2021 GNEA
EXAMINERS AMENDMENT -WRITTEN
Mar 30, 2021 CNEA
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Nov 6, 2020 RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
May 6, 2020 RCSC
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Mar 20, 2020 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Mar 4, 2020 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Mar 4, 2020 OPNR
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Nov 6, 2019 RCSC
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
May 6, 2019 GNS3
LETTER OF SUSPENSION E-MAILED
May 6, 2019 GNSL
SUSPENSION LETTER WRITTEN
May 6, 2019 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 26, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 26, 2019 CRFA
ASSIGNED TO LIE
Apr 25, 2019 ALIE
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Apr 18, 2019 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Apr 18, 2019 REAP
NOTICE OF REVIVAL - MAILED
Apr 18, 2019 NREV
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 18, 2019 TROA
PETITION TO REVIVE-GRANTED
Apr 18, 2019 PETG
TEAS PETITION TO REVIVE RECEIVED
Apr 18, 2019 PROA
REFUSAL PROCESSED BY IB
Nov 2, 2018 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Oct 17, 2018 RFCS
REFUSAL PROCESSED BY MPU
Oct 17, 2018 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Oct 8, 2018 RFCR
NON-FINAL ACTION WRITTEN
Oct 7, 2018 CNRT
APPLICATION FILING RECEIPT MAILED
Oct 5, 2018 MAFR
ASSIGNED TO EXAMINER
Oct 1, 2018 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 1, 2018 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Sep 27, 2018 REPR